Previous close | 160.75 |
Open | 177.26 |
Bid | 174.35 x 45900 |
Ask | 177.43 x 3100 |
Day's range | 177.26 - 177.26 |
52-week range | 143.46 - 193.63 |
Volume | |
Avg. volume | 266 |
Market cap | 75.248B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | 26.11 |
EPS (TTM) | 6.79 |
Earnings date | 01 Aug 2024 |
Forward dividend & yield | 2.36 (1.33%) |
Ex-dividend date | 29 Apr 2024 |
1y target est | N/A |
Today Athinia® announced a collaboration with ASNA to combine unprecedented data sharing and traceability to improve critical semiconductor component and subcomponent innovation. In today's fiercely competitive semiconductor landscape, the quality and reliability of components and subcomponents are paramount for achieving superior yield rates and minimizing defects during manufacturing.
Investing.com -- Shares in Merck KGaA (ETR:MRCG) slumped by more than 10% on Tuesday after the drugmaker announced that it had discontinued a Phase III study evaluating its treatment for patients with head and neck cancer.
Most readers would already know that Merck KGaA's (ETR:MRK) stock increased by 4.5% over the past three months. Given...